An Overview of the Genomic Characterization of Hepatocellular Carcinoma
- Authors
- Yim, Sun Young; Lee, Ju-Seog
- Issue Date
- 2021
- Publisher
- DOVE MEDICAL PRESS LTD
- Keywords
- gene expression profile; RNA-seq; proteomics; mutations; genomic subtypes
- Citation
- JOURNAL OF HEPATOCELLULAR CARCINOMA, v.8, pp.1077 - 1088
- Indexed
- SCIE
- Journal Title
- JOURNAL OF HEPATOCELLULAR CARCINOMA
- Volume
- 8
- Start Page
- 1077
- End Page
- 1088
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/138694
- DOI
- 10.2147/JHC.S270533
- ISSN
- 2253-5969
- Abstract
- Tumor classifications based on alterations in the genome, epigenome, or proteome have revealed distinct tumor subgroups that are associated with clinical outcomes. Several landmark studies have demonstrated that such classifications can significantly improve patient outcomes by enabling tailoring of therapy to specific alterations in cancer cells. Since cancer cells accumulate numerous alterations in many cancer-related genes, it is a daunting task to find and confirm important cancer-promoting alterations as therapeutic targets or biomarkers that can predict clinical outcomes such as survival and response to treatments. To aid further advances, we provide here an overview of the current understanding of molecular and genomic subtypes of hepatocellular carcinoma (HCC). System level integration of data from multiple studies and development of new technical platforms for analyzing patient samples hold great promise for the discovery of new targets for treatment and correlated biomarkers, leading to personalized medicine for treatment of HCC patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.